Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (TSE:CL)
:CL
CL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.75 - C$3.58
Previous CloseN/A
Volume48.59K
Average Volume (3M)153.55K
Market Cap
$368.09M
Enterprise ValueC$1.38B
Total Cash (Recent Filing)$68.34K
Total Debt (Recent Filing)$148.84K
Price to Earnings (P/E)―
Beta1.76
Next Earnings
May 14, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding333,819,460
10 Day Avg. Volume227,822
30 Day Avg. Volume153,553
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)2.60
P/FCF Ratio11.10
Enterprise Value/Market Cap3.75
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.78
Enterprise Value/Ebitda12.07
Forecast
1Y Price Target
C$2.78Price Target Upside251.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Cresco Labs News
PremiumCompany Announcements
Cresco Labs Reports Record Cash Flow in 2024
PremiumCompany Announcements
Cresco Labs Navigates Challenges with Strategic Growth
PremiumCompany Announcements
Cresco Labs Achieves Record Financial Performance in 2024
PremiumCompany Announcements
Cresco Labs Expands into Kentucky’s Medical Cannabis Market---
Options Prices
Currently, No data available
---
Ownership Overview
0.61% Insiders
―
Mutual Funds
― Other Institutional Investors
99.39% Public Companies and
Individual Investors
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was C$0.75 and its highest was C$3.58 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is $368.09M.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is May 14, 2025 which is in 35 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Mar 12, 2025. The company reported C$0 earnings per share for the quarter, beating the consensus estimate of -C$0.003 by C$0.003.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.03.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 333,819,460 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of C$0 in its last earnings report, beating expectations of -C$0.003. Following the earnings report the stock price went down -0.935%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in TSE:CL
---
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$2.78 (251.33% Upside)
C$2.78 (251.33% Upside)
Blogger Sentiment
Neutral
TSE:CL Sentiment 50%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $71.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
News Sentiment
Very Bearish
Bullish news 19%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.00%
12-Months-Change
Fundamentals
Return on Equity
-15.18%
Trailing 12-Months
Asset Growth
-0.23%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of January 27, 2022, it owned and operated 48 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.
---
CL Company Deck
---
CL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Cresco Labs demonstrated strong cash flow and operational improvements, with strategic expansions in key markets. However, these achievements were offset by revenue declines and margin pressures due to price compression and supply constraints. The company is positioning itself for long-term growth, but faces near-term challenges.Read More>---
CL Stock 12 Month Forecast
Average Price Target
C$2.78
▲(251.33% Upside)
Technical Analysis
Best Analysts Covering CL
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-22.28%
reiterated a buy rating 28 days ago
Copying Neal Gilmer's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -22.28% per trade.
---